We list occasional relevant media editorial regarding vaccines, DNA vaccines, and Inovio Pharmaceuticals.

Philadelphia Business Journal 2013 40 Under 40

Ami Shah Brown, Sr. Director of Inovio’s Regulatory Affairs, was named one of the 40-Under-40 Most Promising Executives in the Philadelphia Region

Philadelphia Business Journal
April 2013

Full Article

back to top

H7N9 Vaccine At Least 6 Weeks Away

Dr. Joseph Kim discusses how quickly Inovio could create a DNA vaccine to protect against H7N9

U.S. News & World Report
By Jason Koebler
April 2013

Full Article

back to top

Chinese Government Suspects Human-to-Human Transmission of H7N9 Bird Flu

Inovio CEO Dr. Joseph Kim discusses the increase in H7N9 influenza cases

U.S. News & World Report
By Jason Koebler
April 2013

Full Article

back to top
 

George Mason University Hosts “From Bench to Bedside: DNA Vaccines”

Dr. Joseph Kim & Dr. David Weiner presented their views on biomedical translational research and global market

PWC
By Brent M. Heavner
March 2013

Full Article

back to top
 

Inovio CEO on DNA Vaccines

Dr. Joseph Kim shares his views on the future of DNA vaccines during an interview at The Wall Street Journal’s Unleashing Innovation conference in Singapore 

The Wall Street Journal
By Juro Osawa
February 2013

Full Article

back to top
 

How Drug Makers Think About Innovation

Dr. Joseph Kim of Inovio, Patrick Bergstedt of MSD, and Kiran Mazumda-Shaw of Biocon discuss innovation in medicine with the Wall Street Journal

The Wall Street Journal
By Geeta Anand
February 2013
 
Full Article

back to top
 

Editor’s Pick: Inovio

A Pennsylvania company hopes to turn synthetic DNA vaccines into rapid response agents against flu epidemics and cancer

Nature Biotechnology
By Jennifer Rohn
February 2013

Full Article

back to top 

 

Why the Flu is So Relentless & How Technology Might Help

Researchers are developing quick-brew vaccines and ones that catch multiple strains of flu

MIT Technology Review
By Susan Young
January 28, 2013

Full Article 

back to top
 

Tackling Transfection Tasks

Genetic Engineering & Biotechnology News
By Neil Mckenna, Ph.D.
January 2013
 
Full Article

back to top  
 

University of Pennsylvania & Inovio Test Possible HIV Vaccine

6 ABC Action News
December 2012

Watch Video

back to top 
 

Study Looks at Vaccine to Treat HPV Infection

Times Dispatch
By Tammie Smith
December 2012

Full Article 

back to top 

Company Works to Develop 'Game Changing' HIV Vaccine

Fox 5 Sandiego
By Erica Fox
November 2012

Full Article

back to top

10 Promising Therapeutic Vaccines 2012

Fierce Vaccines
By Suzanne Elvidge
October 2012

Full Article

back to top

The Compelling Need for Game-Changing Influenza Vaccines

An Analysis of the Influenza Vaccine Enterprise and Recommendations for the Future

Center for Infectious Disease Research & Policy
By Michael T. Osterholm, et al.
October 2012

Full Article

back to top

New Vaccine Could Help Women Who Already Have HPV

My Health News Daily
By Rachael Rettner
October 2012

Full Article

back to top

Cervical Cancer Vaccine Shows Promise

Philly.com
By Sandy Bauers
October 2012

Full Article

back to top

Therapeutic Vaccine Shows Potential in Fighting Cervical Cancer

The New York Times
By Roni Caryn Rabin
October 2012

Full Article

back to top

Cervical Cancer Vaccine in Early Stages

CNN Health
By Elizabeth Landau
October 2012

Full Article

back to top

Grand Strand Doctor's Testing Could Save Lives

Carolina Live
By Joel Allen
August 2012

Full Article

back to top

Electroporation Delivery of DNA Vaccines: Prospects for Success

PMC
By Niranjan Y. Sardesai & David B. Weiner
June 2012

Full Article

back to top

Inovio: A Rising Star in the World of Vaccines

eCliniqua
By Deborah Borfitz
September 2011

Full article

back to top


Dermal Electroporation: An Efficient and Tolerable Method of Delivering DNA Vaccines

This article describes the recent advances in dermal electroporation (ID ED) as an efficient platform for the delivery of DNA vaccines. In the future, dermal electroporation devices currently in development could offer an easy-to-use, tolerable, and low-cost strategy for mass immunizations with gene-based vaccines.

Transdermal
By Kate Broderick & Stephen Kemmerrer
January 2011

Article for purchase

back to top


DNA Drugs Come of Age

After years of false starts, a new generation of vaccines and medicines for HIV, influenza and other stubborn illnesses is now in clinical trials.

Scientific American
By Matthew P. Morrow & David B. Weiner
June 2010

Article for purchase

back to top